How to Buy Anika Therapeutics Stock
Anika Therapeutics Inc
Anika Therapeutics, Inc. , a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally.
Anika Therapeutics stock last closed at $9.42, down 1.57% from the previous day, and has decreased 41.96% in one year. It has underperformed other stocks in the Medical Devices industry by 0.09 percentage points. Anika Therapeutics stock is currently +19.7% from its 52-week low of $7.87, and -48.72% from its 52-week high of $18.37.
As of Dec 22, 2025, there are 14.42M ANIK shares outstanding. The market value of ANIK is $135.85M. In the last 24 hours, 166,000 ANIK shares were traded.
How to Buy Anika Therapeutics Stock
Not sure how to invest in Anika Therapeutics stock? Here's how.
- Choose where to buy Anika Therapeutics stock: You need to choose an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you figure out where to buy Anika Therapeutics stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit money your investment account: Pick your method of payment and add your information.
- Analyze Anika Therapeutics stock: The Anika Therapeutics ticker symbol is ANIK. Is Anika Therapeutics stock a good investment? Should you buy shares of ANIK? How do ANIK's underlying business fundamentals look? Do top analysts think Anika Therapeutics is a good buy? Why has ANIK's stock price moved recently? (Hint: Our stock market research website can help you evaluate if ANIK is a good stock to buy).
- Execute your ANIK buy order: Decide if you will purchase ANIK shares at the current market price or use a limit order to buy ANIK shares at a given price.
- Get key alerts regarding your investment in ANIK: Create a watchlist to keep track of your new investment in Anika Therapeutics shares.
Step 1: Choose where to buy Anika Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy ANIK stock.
Our preferred brokerage: eToro
Based on our research, eToro is the best stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal details so you are able to buy ANIK today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start a new brokerage account.
- Submit your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've finished signing up on one of the most highly reviewed stock trading apps, you can securely and quickly fund your account:
Watch this video walkthrough for more details transferring funds into your new investment account.
Step 4: Analyze Anika Therapeutics stock
After you have chosen the best place to buy Anika Therapeutics stock, it's very important to evaluate their stock before you invest, so you can understand the risk as well as the opportunity.
Anika Therapeutics Numbers
ANIK Due Diligence Score
WallStreetZen was created to help part-time investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ANIK's stock page.
What is the fair value of ANIK stock?
You can use many financial metrics, analyses, models, and charts to gauge ANIK's intrinsic value.
Using relative valuations ratios:
- ANIK could be undervalued based on its P/B ratio of 0.93x, relative to Medical Devices industry P/B ratio of 3.91x
You can do additional valuation analysis on ANIK's stock here.
ANIK Financial Health
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the ANIK balance sheet.
- ANIK has a low debt to equity ratio of 0.29.
- There are more short-term assets than short-term liabilities on the ANIK balance sheet.
- ANIK's operating cash flow of $8.13M allows it to safely service it's debt of $22.78M.
- Total ANIK debt is lower than 5 years ago, relative to shareholder equity.
Negative Financial Indicators:
- ANIK profit margin has gone up by 0.72 percentage points in the past year, but the company is still unprofitable.
- ANIK earnings of -$31.21M is not enough to cover its interest payments.
Is Anika Therapeutics stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 1 sell side analysts who give ratings on ANIK, the consensus analyst rating on ANIK is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Anika Therapeutics stock forecast page.
ANIK Momentum
ANIK Revenue
Last year, ANIK revenue was $80.91M. Over the past 5 year, ANIK's revenue has increased by -8.7% per year. This was slower than the Medical Devices industry average of 10.94%.
You can research ANIK's earnings and revenue performance here.
What are ANIK insiders up to?
In the past year, insiders at ANIK have sold more shares than they have bought.
Stephen D. Griffin, EVP CFO COO of ANIK, was the latest ANIK insider to sell. They sold $43,682.71 worth of ANIK stock on Jun 3, 2025.
Get more info about who owns ANIK shares here.
Can I rely on ANIK as an income stream?
No, Anika Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about ANIK?
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your ANIK buy order
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount, place a limit order.
Press the Open button and eToro will place your order.
If you want additional info about investing in stocks on eToro, watch the how to video below:
Step 6: Get key alerts regarding your investment in ANIK
Now that you own some ANIK shares, you'll want to stay up-to-date on your stock purchase.
Make a watchlist to keep tabs on your ANIK stock.
ANIK Feed
How to Buy Stock in Anika Therapeutics
To reiterate, here are the 6 steps for buying Anika Therapeutics stock:
- Choose where to buy Anika Therapeutics stock
- Sign up for a brokerage account
- Deposit money your investment account
- Analyze Anika Therapeutics stock
- Execute your ANIK buy order
- Get key alerts regarding your investment in ANIK
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest news on your investment in Anika Therapeutics, get started below.
More Articles You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.